• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 4 of 19
NewslettersCan an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so
By Lucy BrewsterMay 24, 2023
Pipette adding sample to petri dish with DNA profiles in background
NewslettersA.I.-fueled biotech startups are having a moment—and one just raised $300 million in a Series A
By Lucy BrewsterMay 23, 2023
HealthHow Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By Arthur Allen and KFF Health NewsApril 13, 2023
TechThe Silicon Valley Bank meltdown could be a disaster for downtrodden biotech startups
By Angelica Peebles, Ilena Peng and BloombergMarch 10, 2023
TechThe 11 most promising health tech startups, according to Silicon Valley VCs
By Lucy BrewsterOctober 24, 2022
TechHealth Tech startups are booming. These 11 VC investors are behind some of the hottest deals
By Lucy BrewsterSeptember 23, 2022
Joe Biden in front of an American flag.
FinanceBiden’s new executive order triggers new front in U.S.-China economic competition
By Tristan BoveSeptember 12, 2022
President Joe Biden signs executive order addressing semiconductors shortage in February.
EyebrowBiden to spur biomanufacturing, reduce reliance on China with executive order  
By Riley Griffin and BloombergSeptember 10, 2022
Mother holds child's hand
HealthParents are becoming drug developers to find a cure for their children’s rare diseases
By Jared Whitlock and Kaiser Health NewsJuly 21, 2022
CommentaryESG investors shouldn’t ignore biotech’s potential to deliver change
By Michelle McMurry-HeathMay 2, 2022
Albert Bourla, chairman and chief executive officer of Pfizer Inc., speaks during South By Southwest.
HealthThe most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By Sy Mukherjee and IDEA PharmaApril 20, 2022
female scientists in a lab
FinanceInvestors are moving away from biotech stocks as COVID wanes
By Angelica Peebles and BloombergFebruary 14, 2022
Gloved hand holding pills in front of Sanofi corporate logo
HealthSanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By Jeremy KahnJanuary 7, 2022
A health worker speaks with a patient in the reception area of a Testaro Covid-19 testing site in the Goodwood district of Cape Town, South Africa,
HealthOmicron vaccine to begin clinical trial in South Africa
By Jeremy KahnDecember 6, 2021
Future 50 2021-Moderna
MagazineModerna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?
By Rey MashayekhiDecember 2, 2021
1
  • 2
  • 3
  • 4
  • 5
  • 6
...19
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.